

Case Report

The Cureus Journal of Medical Science is proud to introduce the first Automated Whole Brain Tractography: Clinical Impact in Neurosurgery publishing competition.
The preservation of eloquent brain is foundational to neurosurgery. Over the past decade, Diffusion Tensor Imaging (DTI) has become an important tool for the pre-, intra-, and post-operative visualization of white matter tracts, thereby enabling neurosurgeons to maximally preserve neurologic function. Recent software advances in Automated Whole Brain Tractography (AWBT) now provide a more intuitive and easy-to-use vehicle for visualizing whole brain tractography in surgical patients. This competition looks to showcase practical neurosurgical opportunities stemming from such contemporary software tools.
To document and share clinical experiences related to AWBT, this competition seeks to develop the following neurosurgical-focused publications. Eligible submissions are limited to clinically and commercially available software.
Competition results will be shared with the global neurosurgery and neuroradiology communities, with the goal of bringing genuine progress to their patient communities.
The winner of this competition will be determined by general acclaim of the medical community using Cureus Scholarly Impact Quotient™ (SIQ™) crowdsourcing technology. To encourage dissemination and cross-disciplinary awareness, all published materials will be Open Access and indexed with PubMed Central. We encourage you to contribute!
Program administration has been enabled through the financial support of Synaptive Medical. Article selection, editorial review, peer review, publication, and competition winner determination are strictly independent of the sponsor.
All article submissions will undergo an independent pre-publication peer review conducted by a world-class team of experts.
Article analysis and commentary performed by the peer review panel are strictly independent of the sponsor.
The entry period is now closed. Competition entries appear below as they are published. Now is your chance to rate and discuss these articles. Remember, prizes will be awarded to the three highest-rated articles!
Competition entry and article submission are entirely free. Eligible entries include case reports / case series, technical reports, and review articles. All submitted work must be previously unpublished and should not be under consideration for publication elsewhere.
All articles must be submitted and formatted via the template-driven, self-publishing Cureus platform. Authors are encouraged to include supporting animations and videos within their article submissions. For additional information on publishing with Cureus, please refer to our Author Guide.
Other Stipulations
Three Cureus Scientific Excellence™ prizes will be awarded to the published articles that receive the highest Cureus SIQ™ (Scholarly Impact Quotient™) rating:
1st Place: $5,000 USD
2nd Place: $3,000 USD
3rd Place: $1,500 USD
Subsequent to a formal editorial and peer review, published articles undergo SIQ rating – Cureus’ unique crowdsourced, secondary peer-review process. In addition to measuring engagement, SIQ allows the community-at-large to rate the quality of individual articles. Reviewers assign ratings from 1 to 10 on criteria including clarity and rationale, clinical importance, study design and methods, data analysis, novelty of conclusions and quality of presentation.
Aggregated community SIQ ratings allow clinicians and researchers to quickly assess article quality in a manner similar to that of Amazon® and Yelp® community-based reviews.
As engagement and ratings are critical to winning, authors are highly encouraged to share their published articles via social media and email.
Referral Award
Not interested in submitting related research? Please help further medical discovery by referring this publishing program to relevant colleagues within your network. Be the first to refer the winning article author and you’ll receive $1,000 USD for your efforts.
Please click here to refer this program to colleagues.
Sunshine Act Reporting
Section 6002 of the Affordable Care Act requires applicable manufacturers of covered drugs, devices, biologicals, and medical supplies to report payments or other transfers of value made to physicians and teaching hospitals. For winning article and referral awards paid to “covered recipients,” details of monetary awards shall be supplied to Synaptive Medical for subsequent Sunshine Act reporting.